Trelagliptin succinate action

Trelagliptin (Trelagliptin) succinate is mainly used to treat type 2 diabetes and belongs to the dipeptidyl peptidase-4 (DPP-4) inhibitor drug class. Tretagliptin increases insulin secretion and reduces glucagon secretion by inhibiting the activity of DPP-4 enzyme. It can also improve the body's sensitivity to insulin, allowing the body to use insulin more effectively to regulate blood sugar levels. Trelagliptin can protect pancreatic beta cells from damage, promote insulin secretion and inhibit glucagon secretion, reduce the burden on pancreatic islets, and help protect pancreatic islet function. Trelagliptin is a targeted drug. Patients can use this drug under the guidance of a doctor and take it according to the doctor's instructions.